Return on Equity (ROE) is a crucial metric to evaluate a company's efficiency in using capital. Gilead Sciences has a ROE of 5.7%, lower than the industry average of 17%.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Should You Be Worried About Gilead Sciences, Inc.'s (NASDAQ:GILD) 5.7% Return On Equity?
